URMC / Pathology & Laboratory Medicine / Read Our Blog Contact Us Bethany Bushen Communications & Marketing Manager Follow us on Twitter Cancer Biology, thanks to Green Lizards What can green lizards and “dark matter” teach us about cancer? Gene Study Points Researchers to New Pathway for Leukemia Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease. Chang Receives Patent for Prostate Cancer Treatment Method This month, Chawnshang Chang, Ph.D. received a U.S. patent for a new way to treat prostate cancer. His methods aim to both treat prostate cancer patients and keep it from coming back. In his description Chang notes that patients who are treated with the commonly used method of androgen deprivation therapy (ADT) often experience a return, even after remission. Alumni Spotlight: Dr. Jiaoti Huang, Pathology Chair at Duke University Some pathologists find themselves torn between research and clinical practice, but Dr. Jiaoti Huang, MD, PhD isn't one of them. “If things work well, you don’t have to spend a lot of effort balancing the work,” he said. “For me, the more clinical work I do the more problems and issues that I discover for my research.” Labs Play Critical Role in Lymphoma Immunotherapy Trial UR Medicine Central Labs and UR Medicine Labs have been providing essential, behind-the-scenes services for a cancer immunotherapy trial that recently received a lot of local publicity. 12